Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF LOSSES (unaudited)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF LOSSES (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating expenses:        
Research and development $ 384 $ 379 $ 1,349 $ 1,025
General and administrative 474 509 1,255 1,600
Total operating expenses 858 888 2,604 2,625
Loss from operations (858) (888) (2,604) (2,625)
Other income (expense):        
Gain on change in fair value of derivative liability 1,405 (334) 3,403 421
Gain on conversion of debt 39 39
Interest income (expense), net (5,017) 1 (6,479) 3
Loss before provision for income taxes (4,431) (1,221) (5,641) (2,201)
Provision for income taxes
Net loss $ (4,431) $ (1,221) $ (5,641) $ (2,201)
Net loss per common share, basic and diluted (in dollars per share) $ (0.69) $ (0.88) $ (1.77) $ (1.58)
Weighted average shares outstanding (in shares) 6,440,802 1,392,079 3,183,289 1,392,079